Most Popular

- Advertisement -

categories

Lorem ipsum dolor sit amet, consectetur adipiscing elit. 

Highlights

Technology

Global Powers in 2024: Technology, Military, and Economic Influence Unpacked

As we delve into 2024, the landscape of global power is shaped by a complex interplay of technological advancements, military capabilities, and economic influence. Understanding the dynamics among leading nations requires an examination of their strategic priorities and how they leverage their strengths to assert influence on the world stage. This article unpacks the multifaceted nature of global powers, highlighting the key players in technology, military strength, and economic dominance.
Ticketing system 1

Tickets ‘broken’ after Oasis ‘chaos’, resale site chief alleges

Viagogo's business development manager, Matt Drew, stated that Saturday's ticket sale for the band's first shows in 16 years "descended into chaos."A senior official at a resale site has stated that the ticketing system for shows, including next summer's Oasis concerts, is "broken."Viagogo's business development manager, Matt Drew, said Saturday's ticket sales for the band's first shows in 16 years "descended into chaos."
- Advertisement -
Selected menu has been deleted. Please select the another existing nav menu.

Revolutionary blood vessel disease treatment could save 5,000 Brits from amputation each year

Share It:

Table of Content

A revolutionary therapy may save severe blood flow patients from life-altering amputation.

LimFlow is a new procedure that treats critical limb ischemia, a form of blood vessel disease in which blockages in the arteries cut off blood flow to the legs and feet.

This lifestyle-related disease requires 5,000 UK amputations per year.

However, according to a U.S. study, with LimFlow, three-quarters of patients retain their legs.

Revolutionary blood vessel disease treatment could save 5,000 Brits from amputation each year

As part of an ongoing trial, approximately thirty NHS patients have already received the treatment, in which surgeons insert small tubes into the leg to redirect blood flow around the obstructions and restore supply to the foot. Because of its efficacy, three NHS hospitals have asked to continue using the technology.

Within two years, according to experts, it could be available throughout the NHS.

Dr. Mehdi Shishehbor, a cardiologist at the Harrington Heart and Vascular Institute in Cleveland, Ohio, who headed the US study, describes LimFlow as a novel alternative to major amputation that offers hope where none existed before. The results of this study are outstanding, and it is evident that LimFlow is a potent tool for preventing amputation.

In the United Kingdom, critical limb ischemia affects approximately 60,000 individuals annually. Over time, lipid deposits narrow leg arteries, lowering blood flow to the legs and feet. This slows the healing of incisions and ulcers and increases the likelihood of life-threatening infections.

Treatments like putting a stent, a tiny mesh conduit, into the artery to widen it often fail.

Under local anesthetic, LimFlow implants two tubes into the patient, one through the groyne and one through the ankle. When the tubes meet at the site of the obstruction, they are connected, allowing blood to flow around the deposits.

Tags :

Creative Media News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Creative Media News is your premier source for the latest updates in finance, technology, and world events. Our dedicated team of journalists delivers in-depth analysis, breaking news, and expert opinions to keep you informed and engaged. Whether you’re interested in stock market trends, innovative tech, or global affairs, we’ve got you covered. Stay ahead with our reliable, timely, and insightful content. Join our community of readers who trust Creative Media News for accurate, up-to-date information. Follow us for daily updates and stay connected with the world’s most important stories.

Useful Links

Selected menu has been deleted. Please select the another existing nav menu.